Inducibility of HBD-2 in acute burns and chronic conditions of the lung

The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoprot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Burns 2003-09, Vol.29 (6), p.553-555
Hauptverfasser: Milner, S.M, Cole, A, Ortega, M.R, Bakir, M.H, Gulati, S, Bhat, S, Ganz, T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 555
container_issue 6
container_start_page 553
container_title Burns
container_volume 29
creator Milner, S.M
Cole, A
Ortega, M.R
Bakir, M.H
Gulati, S
Bhat, S
Ganz, T
description The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoproteinase inhibitor, and peptides, such as defensins. Human beta-defensins are cationic antimicrobial peptides with broad and potent microbicidal activity that have been shown to play a role in protecting the healthy lung from infection. To determine the effect of thermal injury on the production of the inducible beta-defensin, human β-defensin-2 (HBD-2), we measured the concentration of HBD-2 by Western blot analysis in bronchoalveolar lavage samples from the lungs of burned patients with and without inhalation injury. Our data demonstrates an increased amount of HBD-2 in the pulmonary airways with thermal injury compared to normal lung. A further substantial increase in levels was noted in chronic lung conditions.
doi_str_mv 10.1016/S0305-4179(03)00145-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73575188</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0305417903001451</els_id><sourcerecordid>73575188</sourcerecordid><originalsourceid>FETCH-LOGICAL-c391t-70d45440439c2c913ddd55d48089335f8fae98225136ac298c79cac5619dcd043</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMoWj9-gpKLoofVZLNpkpP4WQsFD-o5pJOsRrZZTXaF_ntTu-jRuQwMzzszPAgdUnJOCR1fPBFGeFFRoU4JOyOEVrygG2hEpVAFrYjaRKNfZAftpvROcnFJttEOLVUplFAjNJkG24Of-8Z3S9zW-OH6tiixD9hA3zk872NI2ASL4S22wQOGNljf-TaPM969Odz04XUfbdWmSe5g6Hvo5f7u-eahmD1OpjdXswKYol0hiK14VZGKKShBUWat5dxWkkjFGK9lbZySZckpGxsolQShwAAfU2XB5tgeOlnv_YjtZ-9Spxc-gWsaE1zbJy0YF5xKmUG-BiG2KUVX64_oFyYuNSV6ZVD_GNQrPZow_WNQ05w7Gg7084Wzf6lBWQaOB8AkME0dTQCf_jhOBBur1QOXa85lHV_eRZ3AuwDO-uig07b1_7zyDbqpit0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73575188</pqid></control><display><type>article</type><title>Inducibility of HBD-2 in acute burns and chronic conditions of the lung</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Milner, S.M ; Cole, A ; Ortega, M.R ; Bakir, M.H ; Gulati, S ; Bhat, S ; Ganz, T</creator><creatorcontrib>Milner, S.M ; Cole, A ; Ortega, M.R ; Bakir, M.H ; Gulati, S ; Bhat, S ; Ganz, T</creatorcontrib><description>The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoproteinase inhibitor, and peptides, such as defensins. Human beta-defensins are cationic antimicrobial peptides with broad and potent microbicidal activity that have been shown to play a role in protecting the healthy lung from infection. To determine the effect of thermal injury on the production of the inducible beta-defensin, human β-defensin-2 (HBD-2), we measured the concentration of HBD-2 by Western blot analysis in bronchoalveolar lavage samples from the lungs of burned patients with and without inhalation injury. Our data demonstrates an increased amount of HBD-2 in the pulmonary airways with thermal injury compared to normal lung. A further substantial increase in levels was noted in chronic lung conditions.</description><identifier>ISSN: 0305-4179</identifier><identifier>EISSN: 1879-1409</identifier><identifier>DOI: 10.1016/S0305-4179(03)00145-1</identifier><identifier>PMID: 12927979</identifier><identifier>CODEN: BURND8</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Acute Disease ; Adult ; Aged ; Aged, 80 and over ; Anti-Infective Agents - metabolism ; Antimicrobial peptides ; beta-Defensins - metabolism ; Biological and medical sciences ; Biomarkers ; Blotting, Western - methods ; Bronchoalveolar Lavage Fluid ; Burns ; Burns, Inhalation - metabolism ; Chronic Disease ; Defensins ; Humans ; Inhalation injury ; Lung - metabolism ; Lung Diseases - metabolism ; Lung Injury ; Medical sciences ; Middle Aged ; Muramidase - metabolism ; Pneumology ; Pulmonary infections ; Respiratory system : syndromes and miscellaneous diseases ; Respiratory Tract Infections - metabolism</subject><ispartof>Burns, 2003-09, Vol.29 (6), p.553-555</ispartof><rights>2003 Elsevier Ltd and ISBI</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c391t-70d45440439c2c913ddd55d48089335f8fae98225136ac298c79cac5619dcd043</citedby><cites>FETCH-LOGICAL-c391t-70d45440439c2c913ddd55d48089335f8fae98225136ac298c79cac5619dcd043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0305-4179(03)00145-1$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15073698$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12927979$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Milner, S.M</creatorcontrib><creatorcontrib>Cole, A</creatorcontrib><creatorcontrib>Ortega, M.R</creatorcontrib><creatorcontrib>Bakir, M.H</creatorcontrib><creatorcontrib>Gulati, S</creatorcontrib><creatorcontrib>Bhat, S</creatorcontrib><creatorcontrib>Ganz, T</creatorcontrib><title>Inducibility of HBD-2 in acute burns and chronic conditions of the lung</title><title>Burns</title><addtitle>Burns</addtitle><description>The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoproteinase inhibitor, and peptides, such as defensins. Human beta-defensins are cationic antimicrobial peptides with broad and potent microbicidal activity that have been shown to play a role in protecting the healthy lung from infection. To determine the effect of thermal injury on the production of the inducible beta-defensin, human β-defensin-2 (HBD-2), we measured the concentration of HBD-2 by Western blot analysis in bronchoalveolar lavage samples from the lungs of burned patients with and without inhalation injury. Our data demonstrates an increased amount of HBD-2 in the pulmonary airways with thermal injury compared to normal lung. A further substantial increase in levels was noted in chronic lung conditions.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Infective Agents - metabolism</subject><subject>Antimicrobial peptides</subject><subject>beta-Defensins - metabolism</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Blotting, Western - methods</subject><subject>Bronchoalveolar Lavage Fluid</subject><subject>Burns</subject><subject>Burns, Inhalation - metabolism</subject><subject>Chronic Disease</subject><subject>Defensins</subject><subject>Humans</subject><subject>Inhalation injury</subject><subject>Lung - metabolism</subject><subject>Lung Diseases - metabolism</subject><subject>Lung Injury</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Muramidase - metabolism</subject><subject>Pneumology</subject><subject>Pulmonary infections</subject><subject>Respiratory system : syndromes and miscellaneous diseases</subject><subject>Respiratory Tract Infections - metabolism</subject><issn>0305-4179</issn><issn>1879-1409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1LAzEQhoMoWj9-gpKLoofVZLNpkpP4WQsFD-o5pJOsRrZZTXaF_ntTu-jRuQwMzzszPAgdUnJOCR1fPBFGeFFRoU4JOyOEVrygG2hEpVAFrYjaRKNfZAftpvROcnFJttEOLVUplFAjNJkG24Of-8Z3S9zW-OH6tiixD9hA3zk872NI2ASL4S22wQOGNljf-TaPM969Odz04XUfbdWmSe5g6Hvo5f7u-eahmD1OpjdXswKYol0hiK14VZGKKShBUWat5dxWkkjFGK9lbZySZckpGxsolQShwAAfU2XB5tgeOlnv_YjtZ-9Spxc-gWsaE1zbJy0YF5xKmUG-BiG2KUVX64_oFyYuNSV6ZVD_GNQrPZow_WNQ05w7Gg7084Wzf6lBWQaOB8AkME0dTQCf_jhOBBur1QOXa85lHV_eRZ3AuwDO-uig07b1_7zyDbqpit0</recordid><startdate>20030901</startdate><enddate>20030901</enddate><creator>Milner, S.M</creator><creator>Cole, A</creator><creator>Ortega, M.R</creator><creator>Bakir, M.H</creator><creator>Gulati, S</creator><creator>Bhat, S</creator><creator>Ganz, T</creator><general>Elsevier Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20030901</creationdate><title>Inducibility of HBD-2 in acute burns and chronic conditions of the lung</title><author>Milner, S.M ; Cole, A ; Ortega, M.R ; Bakir, M.H ; Gulati, S ; Bhat, S ; Ganz, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c391t-70d45440439c2c913ddd55d48089335f8fae98225136ac298c79cac5619dcd043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Infective Agents - metabolism</topic><topic>Antimicrobial peptides</topic><topic>beta-Defensins - metabolism</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Blotting, Western - methods</topic><topic>Bronchoalveolar Lavage Fluid</topic><topic>Burns</topic><topic>Burns, Inhalation - metabolism</topic><topic>Chronic Disease</topic><topic>Defensins</topic><topic>Humans</topic><topic>Inhalation injury</topic><topic>Lung - metabolism</topic><topic>Lung Diseases - metabolism</topic><topic>Lung Injury</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Muramidase - metabolism</topic><topic>Pneumology</topic><topic>Pulmonary infections</topic><topic>Respiratory system : syndromes and miscellaneous diseases</topic><topic>Respiratory Tract Infections - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Milner, S.M</creatorcontrib><creatorcontrib>Cole, A</creatorcontrib><creatorcontrib>Ortega, M.R</creatorcontrib><creatorcontrib>Bakir, M.H</creatorcontrib><creatorcontrib>Gulati, S</creatorcontrib><creatorcontrib>Bhat, S</creatorcontrib><creatorcontrib>Ganz, T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Burns</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milner, S.M</au><au>Cole, A</au><au>Ortega, M.R</au><au>Bakir, M.H</au><au>Gulati, S</au><au>Bhat, S</au><au>Ganz, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inducibility of HBD-2 in acute burns and chronic conditions of the lung</atitle><jtitle>Burns</jtitle><addtitle>Burns</addtitle><date>2003-09-01</date><risdate>2003</risdate><volume>29</volume><issue>6</issue><spage>553</spage><epage>555</epage><pages>553-555</pages><issn>0305-4179</issn><eissn>1879-1409</eissn><coden>BURND8</coden><abstract>The respiratory tract produces a number of molecules that act in the first line of host defense to protect against pathogenic colonization and tissue invasion. Most of the innate antimicrobial activity can be attributed to airway fluid proteins, such as lysozyme, lactoferrin, and secretory leukoproteinase inhibitor, and peptides, such as defensins. Human beta-defensins are cationic antimicrobial peptides with broad and potent microbicidal activity that have been shown to play a role in protecting the healthy lung from infection. To determine the effect of thermal injury on the production of the inducible beta-defensin, human β-defensin-2 (HBD-2), we measured the concentration of HBD-2 by Western blot analysis in bronchoalveolar lavage samples from the lungs of burned patients with and without inhalation injury. Our data demonstrates an increased amount of HBD-2 in the pulmonary airways with thermal injury compared to normal lung. A further substantial increase in levels was noted in chronic lung conditions.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>12927979</pmid><doi>10.1016/S0305-4179(03)00145-1</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-4179
ispartof Burns, 2003-09, Vol.29 (6), p.553-555
issn 0305-4179
1879-1409
language eng
recordid cdi_proquest_miscellaneous_73575188
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Acute Disease
Adult
Aged
Aged, 80 and over
Anti-Infective Agents - metabolism
Antimicrobial peptides
beta-Defensins - metabolism
Biological and medical sciences
Biomarkers
Blotting, Western - methods
Bronchoalveolar Lavage Fluid
Burns
Burns, Inhalation - metabolism
Chronic Disease
Defensins
Humans
Inhalation injury
Lung - metabolism
Lung Diseases - metabolism
Lung Injury
Medical sciences
Middle Aged
Muramidase - metabolism
Pneumology
Pulmonary infections
Respiratory system : syndromes and miscellaneous diseases
Respiratory Tract Infections - metabolism
title Inducibility of HBD-2 in acute burns and chronic conditions of the lung
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T21%3A52%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inducibility%20of%20HBD-2%20in%20acute%20burns%20and%20chronic%20conditions%20of%20the%20lung&rft.jtitle=Burns&rft.au=Milner,%20S.M&rft.date=2003-09-01&rft.volume=29&rft.issue=6&rft.spage=553&rft.epage=555&rft.pages=553-555&rft.issn=0305-4179&rft.eissn=1879-1409&rft.coden=BURND8&rft_id=info:doi/10.1016/S0305-4179(03)00145-1&rft_dat=%3Cproquest_cross%3E73575188%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73575188&rft_id=info:pmid/12927979&rft_els_id=S0305417903001451&rfr_iscdi=true